William B. Stilley III

This profile gathers the share dealings of William B. Stilley III across 2 companies, led by Adial Pharmaceuticals, Inc. and Sysorex, Inc. Over a trading history stretching from 31 July 2018 to 23 May 2023, the count stands at 13 filings.

Every open-market trade on record is a purchase: 5 purchases worth €79k, and no sale. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 5 share grants.

A typical purchase (the median) is worth €20k. Clusters matter here: 2 out of 4 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 25 May 2023, the filings show a share grant in Adial Pharmaceuticals, Inc. The last purchase on record was published on 1 December 2021, which is 1,788 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.